[Construction of Saccharopolyspora erythraea M synthesizing a novel ketolide 3-deoxy-3-oxo-erythronolide B].
Genetic engineering on macrolide antibiotics was a new field in recent years and more than 100 novel polyketides had been produced until then. Using genomic DNA of S. erythraea A226 as a template, about 3.2 kb DNA fragment without KR6 domain was amplified by overlapping PCR technique and cloned into pWHM3 carrier, which resulted in the construction of homologous recombinant plasmid pWHM2201. Plasmid pWHM2201 was introduced into protoplasts of S. erythraea A226 by PEG-mediated transformation and integrated into the gene locus for erythromycin biosynthesis. After integrants grew for two generations on R3M media without Tsr, they were protoplasted and grown on R3M plates. By PCR identification, 8 mutants without KR6 domain were selected out and named S. erythraea M(1-8). With the identification of mass spectrometry, it was proved that S. erythraea M1 synthesized a novel ketolide compound 3-deoxy-3-oxo-erythronolide B.
Zhang
Bu-Chang
BC
Beijing Institute of Biotechnology, Beijing 100850, China.
Zhao
Zhi-Hu
ZH
Wang
Yi-Guang
YG
Ma
Qing-Jun
QJ
D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry; D002876:Chromosomes, Bacterial; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000096:biosynthesis* / Q000737:chemistry; D005818:Genetic Engineering; D048628:Ketolides; D015394:Molecular Structure; D009097:Multienzyme Complexes / Q000235:genetics; D016930:Saccharopolyspora / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*
C466821:3-deoxy-3-oxo-erythronolide B; D000900:Anti-Bacterial Agents; D048628:Ketolides; D009097:Multienzyme Complexes; C038315:erythronolide B; D004917:Erythromycin